These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 6461117

  • 21. Regulation of human allograft rejection: kidney-infiltrating suppressor inducer and suppressor effector T-cells are reduced during rejection.
    Tötterman TH, Hanås E, Larsson E, Sjöberg O, Tufveson G.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):359-60. PubMed ID: 2523133
    [No Abstract] [Full Text] [Related]

  • 22. Delineation of human thymocyte differentiation pathways utilizing double-staining techniques with monoclonal antibodies.
    Tidman N, Janossy G, Bodger M, Granger S, Kung PC, Goldstein G.
    Clin Exp Immunol; 1981 Sep; 45(3):457-67. PubMed ID: 6461444
    [Abstract] [Full Text] [Related]

  • 23. Immunologic monitoring with monoclonal antibodies to human T-cell subsets.
    Cosimi AB, Colvin RB, Burton RC, Winn HJ, Rubin R, Goldstein G, Kung PC, Hoffman RA, Hansen WP, Russell PS.
    Transplant Proc; 1981 Sep; 13(3):1589-93. PubMed ID: 7029820
    [No Abstract] [Full Text] [Related]

  • 24. Ability of a CD4-positive, MRC OX22 "low" T-cell subpopulation to initiate renal allograft rejection in the athymic nude rat.
    Bradley JA, Bolton EM, Briggs JD, Gracie JA.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):326-7. PubMed ID: 2650138
    [No Abstract] [Full Text] [Related]

  • 25. Human renal allograft infiltrating T cells: phenotype-function correlation and clonal heterogeneity.
    Miceli MC, Barry TS, Finn OJ.
    Transplant Proc; 1988 Apr; 20(2):199-201. PubMed ID: 3284040
    [No Abstract] [Full Text] [Related]

  • 26. Mechanisms of autoimmune liver disease.
    Meyer zum Büschenfelde KH, Manns M.
    Semin Liver Dis; 1984 Feb; 4(1):26-35. PubMed ID: 6231727
    [No Abstract] [Full Text] [Related]

  • 27. T11+/DR+ lymphocytes in renal allograft recipients with irreversible rejection.
    Hayes JM, Valenzuela R, Novick AC, Steinmuller DR.
    Transplantation; 1988 Apr; 45(4):806-9. PubMed ID: 2895969
    [No Abstract] [Full Text] [Related]

  • 28. Role of T-cell-subset monitoring in renal-allograft recipients.
    Morris PJ, Carter NP, Cullen PR, Thompson JF, Wood RF.
    N Engl J Med; 1982 May 06; 306(18):1110-1. PubMed ID: 7040954
    [No Abstract] [Full Text] [Related]

  • 29. Mechanisms of kidney allograft rejection.
    Najarian JS, Foker JE.
    Transplant Proc; 1969 Mar 06; 1(1):184-93. PubMed ID: 4944216
    [No Abstract] [Full Text] [Related]

  • 30. Suppression and stimulation of T cell clones of renal transplant recipients by autologous post-transplant sera: a role for regulatory antibodies.
    Daniel V, Opelz G.
    Transplant Proc; 1987 Oct 06; 19(5):4210-3. PubMed ID: 2960049
    [No Abstract] [Full Text] [Related]

  • 31. The real meaning of changing peripheral blood helper to cytotoxic/suppressor cell ratio during renal allograft rejection.
    Kovithavongs T, Dossetor JB.
    Transplant Proc; 1984 Dec 06; 16(6):1486-9. PubMed ID: 6239421
    [No Abstract] [Full Text] [Related]

  • 32. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    Hess AD, Donnenberg AD, Tutschka PJ, Santos GW.
    J Immunol; 1983 Feb 06; 130(2):717-21. PubMed ID: 6217251
    [No Abstract] [Full Text] [Related]

  • 33. CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection.
    Battochio A, Solez K, Poppema S, Cockfield S, Rayner D.
    Transplant Proc; 1996 Feb 06; 28(1):482-3. PubMed ID: 8644320
    [No Abstract] [Full Text] [Related]

  • 34. Assessment of fine needle aspiration biopsies from renal transplants using monoclonal antibodies as lymphocyte markers.
    Waugh J, Bishop A, Hall BM, Philips J, Duggin G, Tiller D, Sheil A, Horvath J.
    Transplant Proc; 1986 Apr 06; 18(2):267-9. PubMed ID: 3515663
    [No Abstract] [Full Text] [Related]

  • 35. Subsets of T lymphocyte subpopulations after human marrow transplantation defined by monoclonal antibodies and two-color fluorescence.
    Farrell C, Atkinson K, Chapman G, Penny R, Biggs J.
    Transplant Proc; 1985 Apr 06; 17(2):1704-6. PubMed ID: 3885509
    [No Abstract] [Full Text] [Related]

  • 36. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P, Kern F, Fietze E, Döcke WD, Ewert R, Emmrich F, Volk HD.
    Transplant Proc; 1995 Feb 06; 27(1):859-62. PubMed ID: 7879207
    [No Abstract] [Full Text] [Related]

  • 37. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R, Poindexter NJ, Woodle ES, Hussain MS, Mohanakumar T, Scharp DW.
    Transplantation; 1994 Jun 15; 57(11):1555-62. PubMed ID: 8009588
    [Abstract] [Full Text] [Related]

  • 38. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL, Nelson PW, Colvin RB, Cosimi AB.
    Transplant Proc; 1984 Dec 15; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.